HeXun Biosciences CoROCO:6986 23 Market Cap is NT$2,450.3 Mil as of Jul. 12, 2026. GuruFocus rates ROCO:6986 with a GF Score™ of 23/100. The stock has 1 warning sign investors should review. Among 1,423 Biotechnology companies, HeXun Biosciences Co ranks worse than 57.06% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). HeXun Biosciences Co's share price for the quarter that ended in Dec. 2025 was NT$63.4. HeXun Biosciences Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 52.1 Mil. Therefore, HeXun Biosciences Co's market cap for the quarter that ended in Dec. 2025 was NT$3,305.3 Mil.
HeXun Biosciences Co's quarterly market cap
declined
from Jun. 2025 (NT$3,394.8 Mil) to Sep. 2025 (NT$2,994.6 Mil) but then
increased
from Sep. 2025 (NT$2,994.6 Mil) to Dec. 2025 (NT$3,305.3 Mil).
HeXun Biosciences Co's annual market cap
increased
from Dec. 2023 (NT$2,980.8 Mil) to Dec. 2024 (NT$3,059.0 Mil) and
increased
from Dec. 2024 (NT$3,059.0 Mil) to Dec. 2025 (NT$3,305.3 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. HeXun Biosciences Co's Enterprise Value for Today is NT$1,977.2 Mil.
HeXun Biosciences Co (ROCO:6986) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
HeXun Biosciences Co Market Cap Related Terms
HeXun Biosciences Co Market Cap Historical Data
* Premium members only.
The historical data trend for HeXun Biosciences Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6986 vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, HeXun Biosciences Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HeXun Biosciences Co Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, HeXun Biosciences Co's Market Cap distribution charts can be found below:
* The bar in red indicates where HeXun Biosciences Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
HeXun Biosciences Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HeXun Biosciences Co (ROCO:6986) has a Market Cap of NT$2,450.3 Mil as of Jul. 12, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on HeXun Biosciences Co and its competitors. According to the industry distribution chart, HeXun Biosciences Co ranks #812 out of 1423 companies in the Biotechnology industry, placing it in the top 57.1%.
Is HeXun Biosciences Co's Market Cap too high?
HeXun Biosciences Co's current Market Cap is NT$2,450.3 Mil. Based on the distribution chart, HeXun Biosciences Co ranks #812 out of 1423 companies in the Biotechnology industry, which is below the industry midpoint. Overall, HeXun Biosciences Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does HeXun Biosciences Co's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, HeXun Biosciences Co ranks #812 out of 1423 companies for Market Cap. This places HeXun Biosciences Co in the lower half of its industry. The industry median Market Cap is 121.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 121.30, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on HeXun Biosciences Co and its competitors. For the Biotechnology industry, the median Market Cap is 121.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HeXun Biosciences Co's current Market Cap is NT$2,450.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeXun Biosciences Co stock overvalued right now?
HeXun Biosciences Co (ROCO:6986) has a current Market Cap of NT$2,450.3 Mil. The current Market Cap is NT$2,450.3 Mil. HeXun Biosciences Co's overall GF Score™ is 23/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For HeXun Biosciences Co (ROCO:6986), the current Market Cap is NT$2,450.3 Mil as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
HeXun Biosciences Co Ltd is engaged in the research and development of cell drugs and cell derivatives. It conducts research and development jointly with medical research institutions to use stem cells to treat cardiovascular, immune-inflammatory, and neurodegenerative diseases to develop innovative cell drugs and treatment methods. The company's main business items are new drug research and development, biotechnology services, and research and development services, such as: commissioned research and development and production services for cell medicine, agency testing and development services, and biomedical consulting services, etc.
23GF Score
Get the complete analysis for ROCO:6986
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6986 has been successfully added to your 
